Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study

NCT07108595 · clinicaltrials.gov ↗

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: T- Dxd

Sponsor

The First Affiliated Hospital with Nanjing Medical University